|
||
| Rebif News Channel: 52 articles |  |
|
|
|||||
|
|||||
|
|||||
| MS NEWS ARCHIVES: by week | |||||
 |
|||||
 |
|||||
 |
|||||
 |
|||||
 |
|||||
 |
|||||
| HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS | |||||
 |
|||||
| |||||
| |||||
 Click to view 1280 MS Walk photos! | |||||
|
|||||
|
|||||
|
|||||
Wednesday
Precautions While Using Rebif
LINKRebif should not be used during pregnancy or breast-feeding, or by any woman who is trying to become pregnant.
Women taking Rebif should use birth control measures at all times.
If you become pregnant while using Rebif, stop the treatment and contact your physician.
There was no increase in depression reported by people receiving Rebif in the clinical trial.
However, some patients treated with interferons, including Rebif, have become seriously depressed, and depression and suicidal thoughts are known to occur with some frequency in MS.
It is recommended that individuals with a history of severe depressive disorder be closely monitored while taking Rebif.
Anyone who experiences significant feelings of sadness or helplessness, or feels like hurting him- or herself or others, should consult with family or friends and their physician as soon as possible.
Rebif can affect liver function. Your physician may require regular blood tests to assess liver function.
If you notice that your skin or the whites of your eyes become yellow, or if you are bruising more easily than usual, contact your physician.
A post-marketing case of liver failure has been reported in a person taking Rebif along with another medication that was potentially toxic to the liver.
Because of the potential of Rebif to affect the levels of red and white blood cells and platelets in a person's system, blood tests are recommended at regular intervals.
Thyroid function tests are recommended every 6 months in patients with a history of thyroid dysfunction.
Women taking Rebif should use birth control measures at all times.
If you become pregnant while using Rebif, stop the treatment and contact your physician.
There was no increase in depression reported by people receiving Rebif in the clinical trial.
However, some patients treated with interferons, including Rebif, have become seriously depressed, and depression and suicidal thoughts are known to occur with some frequency in MS.
It is recommended that individuals with a history of severe depressive disorder be closely monitored while taking Rebif.
Anyone who experiences significant feelings of sadness or helplessness, or feels like hurting him- or herself or others, should consult with family or friends and their physician as soon as possible.
Rebif can affect liver function. Your physician may require regular blood tests to assess liver function.
If you notice that your skin or the whites of your eyes become yellow, or if you are bruising more easily than usual, contact your physician.
A post-marketing case of liver failure has been reported in a person taking Rebif along with another medication that was potentially toxic to the liver.
Because of the potential of Rebif to affect the levels of red and white blood cells and platelets in a person's system, blood tests are recommended at regular intervals.
Thyroid function tests are recommended every 6 months in patients with a history of thyroid dysfunction.